Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.26K Buy
384
+40
+12% +$509 ﹤0.01% 41
2025
Q4
$5.64K Sell
344
-206
-37% -$3.21K ﹤0.01% 34
2025
Q3
$7.36K Sell
550
-150
-21% -$1.77K ﹤0.01% 34
2025
Q2
$8.96K Sell
700
-600
-46% -$7.2K ﹤0.01% 28
2025
Q1
$13.4K Buy
1,300
+650
+100% +$8.37K ﹤0.01% 28
2024
Q4
$8.26K Sell
650
-2,000
-75% -$26.4K ﹤0.01% 31
2024
Q3
$33.9K Sell
2,650
-150
-5% -$1.84K 0.01% 24
2024
Q2
$35.5K Buy
2,800
+2,150
+331% +$37.2K 0.01% 25
2024
Q1
$14.7K Buy
+650
New +$15.2K 0.01% 31
2023
Q4
Sell
-600
Closed -$10.3K 66
2023
Q3
$10.3K Hold
600
﹤0.01% 38
2023
Q2
$9.94K Sell
600
-25
-4% -$401 ﹤0.01% 37
2023
Q1
$11K Sell
625
-425
-40% -$6.42K 0.01% 37
2022
Q4
$13.3K Buy
1,050
+475
+83% +$5.87K 0.01% 39
2022
Q3
$7K Buy
575
+275
+92% +$4.82K ﹤0.01% 43
2022
Q2
$5K Buy
300
+125
+71% +$2.34K ﹤0.01% 42
2022
Q1
$4K Buy
+175
New +$5.9K ﹤0.01% 35

Other funds holding PATH

Performa Ltd (US)'s PATH Position: Q1 2026 in Review

Performa Ltd (US) increased its UiPath (PATH) stake by 12% in Q1 2026, buying an estimated $509 and bringing the position to 384 shares worth $4.26K. The position accounts for ﹤0.01% of the portfolio, ranked #41.

Performa Ltd (US) first reported a position in PATH in Q1 2022 and has held it in 16 quarters since. The position peaked at $35.5K in Q2 2024. 533 funds tracked by Wall St. Rank hold PATH as of Q1 2026.

  • Performa Ltd (US) held 384 shares of UiPath worth $4.26K as of Q1 2026.
  • Performa Ltd (US) bought 40 UiPath shares in Q1 2026, an estimated $509.
  • UiPath made up ﹤0.01% of Performa Ltd (US)'s portfolio in Q1 2026, its #41 holding.
  • Performa Ltd (US) first reported a position in UiPath in Q1 2022 and has held it in 16 quarters since.
  • Performa Ltd (US)'s UiPath position peaked at $35.5K in Q2 2024.
  • 533 funds tracked by Wall St. Rank held UiPath as of Q1 2026.

Based on Performa Ltd (US)'s 13F filing for Q1 2026, filed 6 May 2026.